Prism Medico and Pharmacy Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
For the full year, sales was INR 29.25 million compared to INR 12.71 million a year ago. Revenue was INR 30.48 million compared to INR 12.72 million a year ago. Net loss was INR 0.214 million compared to INR 0.763 million a year ago. Basic loss per share from continuing operations was INR 0.05 compared to INR 0.13 a year ago. Diluted loss per share from continuing operations was INR 0.05 compared to INR 0.13 a year ago. Basic loss per share was INR 0.05 compared to INR 0.13 a year ago. Diluted loss per share was INR 0.05 compared to INR 0.13 a year ago.